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Heart failure (HF) is a complex clinical syndrome that represents a
growing public health problem [1,2]. Cardiac resynchronization
therapy (CRT) is one of the surgical procedures proposed to HF
treatment. Nevertheless, although its efﬁcacy – both in isolated
therapy (CRT-P) and combined with cardiac deﬁbrillators (CRT-D) –
has been shown in randomized clinical trials [3–8] and recently
demonstrated for patients with less functional impairment [9,10], its
effectiveness in the real world should be better evaluated.
In middle income countries, such as Brazil, the effectiveness of CRT
in the mid- and long run is unknown. The public expenses with the
procedure are high in the country, despite the lack of detailed
information on the ﬁnal outcome of patients submitted to the implant.
This scenario represents a major challenge for healthcare managers
who aim at administrative efﬁciency and real improvement in quality
of life and survival of patients.
So the present study analyzed, in the period from 2002 to 2007, the
effectiveness of CRT in the Brazilian public services managed and
ﬁnanced by the Uniﬁed Health System (SUS, acronym in Portuguese),
who assists approximately 80% of the population [11].
The project was approved by the Institutional Review Board of the
Universidade Federal deMinas Geraiswith agreement of themanager of
the Ministry of Health in country.
Themethod proposed for the study based on the linkage of records
from ofﬁcial health databases. The Hospital Information System of the
Uniﬁed Health System (SIH, acronym in Portuguese) and Mortality
Information System (SIM, acronym in Portuguese), two large databases
available in the country, were selected.
The RecLink III (RL3) software, a public domain tool, version 3.1,
was used to apply the probabilistic linkage [12]. Pilot studies were
conducted and processing details have been described in a previous
study conducted by the same group of researchers [13].
The date of the ﬁrst implant identiﬁed in the period deﬁned for the
study, was considered as the beginning of observation for each
individual (T0). The limit entry date for new cases was the last day of
2007, and the ﬁnal date of follow-up was the last date with
information available at the SIM (December 31, 2008). So, a “National
Database of Multisite Pacemaker” consisting of 3526 patients was
established from January 1st, 2002 to December 31st, 2007.
The Statistical Package for Social Sciences— SPSS, version 18.0, was
used for all analyses. The nonparametric Kaplan-Meier estimator was
used to calculate the survival functions, and T0 up to date of death was
considered the endpoint. The log-rank test was employed to compare
the survival functions for co-variables. The Cox proportional hazards
model was used and hazard-ratios (HR) and their respective 95%
conﬁdence intervals (CI) were calculated.
The mean follow-up was 2.8 years (maximum 7 years) and the
baseline characteristics of the ﬁnal cohort are described in Table 1.
After linkage between SIH and SIM databases, a total of 1332 deaths
referred primarily to cardiac causes were identiﬁed, ﬁfty of them
occurred during the same admission of the index procedure.
The overall survival of patients submitted to CRT in the country was
80.1% (95% CI 79.4–80.8) in one year and 55.6% (95% CI 54.6–56.6) in
5 years, whereas the median overall survival was 30.3 months (IQR,
16.1–50.9). When analyzed separately, CRT-P (N=2811) was 87% and
55.4% in 1 and 5 years, and CRT-D (N=715) was 83.4% and 52.3%. A
statistically signiﬁcant difference in the incidence of events for the
variable sex (pb0.0001) was demonstrated. Furthermore, in univariate
analysis, improved survival – albeit within limits – was observed in the
cohort studied, from 2002 throughout 2007 (p=0.055) (Fig. 1).
There was no statistically signiﬁcant difference in the survival
curves when analyzing age (log-rank: p=0.230), CRT-P or CRT-D
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Table 1
Baseline characteristics of the study population.
Variables Patients (N=3526)
Age, mean±SD, (years) 59.8±13.3
Males, N (%) 2316 (66)
Leading causes of hospitalization, N (%)
Total atrioventricular block 660 (18.7)
Not speciﬁed heart failure 657 (18.6)
Dilated cardiomyopathy 608 (17.2)
Ischemic cardiomyopathy 475 (13.5)
Ventricular tachycardia 322 (9.1)
Types of CRT devices, N (%)
CRT-P 2811 (79.7)
CRT-D 715 (20.3)
Implant technique, N (%)
Endocardiac (transvenous) 1701 (83.4)
Epicardic (minithoracotomy) 584 (16.6)
Admission by state, N (%)
São Paulo 1883 (53.4)
Minas Gerais 209 (5.9)
Bahia 173 (4.9)
Others states 1261 (35.8)
Median length of hospital stay, (IQR),(days) 4.0 (2.0–9.0)
Juridical nature of hospital, N (%)
Charity Hospital 1472 (41.7)
SUS Hospital 1067 (29.7)
Contracted Hospital 697 (19.8)
University Hospital 310 (8.8)
Nature of hospitalization, N (%)
Urgency / Emergency 2296 (65.1)
Elective 1230 (34.9)
SD: standard deviation; CRT-P: cardiac resynchronization therapy pacemakers;
CRT-D: cardiac resynchronization therapy deﬁbrillators; IQR: interquartile range;
SUS: uniﬁed health system
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(log-rank: p=0.237) and endocardiac or epicardic implant technique
(log-rank: p=0.321). The variables included in the ﬁnal Cox
regression model are listed in Table 2.
This is the largest observational study evaluating the effectiveness
of CRT performed in a public health system, and applying the
methodology of probabilistic linkage to ofﬁcial healthcare databases.
Our results demonstrated a favorable outcome of patients submitted
to CRT, considering improved survival throughout the years studied
and overall survival, in one and 5 years. Despite smaller percentages,
especially in the ﬁrst year of implant, as compared to those obtained in
the randomized clinical trials [3,4] and in the observational studies
[14,15], the results observed showed better quality of care delivered to
patients with advanced HF by the public health system.
This improved outcome along the years seems to result from
measures adopted by public managers responsible for high-
complexity cardiovascular procedures in the country. The regulation
of the procedure by the Ministry of Health, as from 2004, allowed
setting qualiﬁed centers, credentialed according to technical criteria
and populational parameters [16,17]. Such process certainly contrib-
uted to improved overall survival in the study, by providing incentives
in terms of technical training of the professionals involved, which
resulted in more strict indications for the procedures, less of pre- and
postoperative complications, optimization of generator programming,
together with technological improvement of the devices and equip-
ment offered by specialized industries.
In this series no difference in survival between the CRT-P and the
CRT-D was observed. Although our observation is in agreement with
other studies,[18] a more comprehensive analysis of this ﬁnding was
hindered due to absence of clinical variables in the listed databases,
especially the SIH employed in the study, acknowledged as a primarily
administrative database. This fact contributed to limitations of the
study, since the lack of speciﬁc clinical data in the listed databases,
such as the NYHA functional class, LVEF, presence or not of atrial
ﬁbrillation, drugs on use, QRS width and co-morbid conditions,
hindered adjustment of the results for these variables.
Therefore, it was concluded that effectiveness of the CRT veriﬁed in
the real world is similar to that of the large clinical trials. Furthermore,
throughout the years assessed, there was improvement in survival of
the patients submitted to implant in the public health system. In this
context, economic analyses are still needed to evaluate cost-
effectiveness of the procedure in middle-income countries.
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Fig. 1. Overall survival curve of 3526 patients submitted to CRT at hospitals of the SUS/
Brazil in the period 2002–2007 (p=0.055).
Table 2
Cox proportional hazard regression analysis (ﬁnal model).
Covariate b s.e. P-value Exp(b) 95% CI for Exp(b)
Sex 0.348 0.061 0.000 1.416 1.257–1.596
Age (in decades) 0.043 0.021 0.038 1.044 1.002–1.088
Year of Implant (2002) 0.046
Year of Implant (2003) 0.193 0.066 0.003 1.213 1.066–1.381
Year of Implant (2004) 0.063 0.059 0.285 1.065 0.949–1.197
Year of Implant (2005) −0.066 0.058 0.255 0.936 0.836–1.049
Year of Implant (2006) −0.051 0.060 0.393 0.950 0.844–1.069
Year of Implant (2007) −0.037 0.064 0.561 0.963 0.849–1.093
95% CI, 95% conﬁdence interval; b, logistic regression coefﬁcient; P, signiﬁcance
level; s.e., standard error of logistic regression coefﬁcient.
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